Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
Authors:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 12 (2) , 187-200
Abstract
Head-and-neck cancer is a major form of the disease worldwide. Treatment consists of surgery, radiation therapy and chemotherapy, but these have not resulted in improved survival rates over the past few decades. Versatile nanoparticles, with selective tumor targeting, are considered to have the potential to improve these poor outcomes. Application of nanoparticle-based targeted therapeutics has extended into many areas, including gene silencing, chemotherapeutic drug delivery, radiosensitization, photothermal therapy, and has shown much promise. In this review, we discuss recent advances in the field of nanoparticle-mediated targeted therapeutics for head-and-neck cancer, with an emphasis on the description of targeting points, including future perspectives.Keywords
This publication has 99 references indexed in Scilit:
- Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growthMolecular Cancer Therapeutics, 2008
- Protein kinase CK2 – A key suppressor of apoptosisAdvances in Enzyme Regulation, 2008
- Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical–translational studiesToxicology and Applied Pharmacology, 2007
- Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProceedings of the National Academy of Sciences, 2007
- Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphologyProceedings of the National Academy of Sciences, 2006
- Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER databaseInternational Journal of Cancer, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Functional comparison of single- and double-stranded siRNAs in mammalian cellsBiochemical and Biophysical Research Communications, 2004
- Nanocapsule Technology: A ReviewCritical Reviews™ in Therapeutic Drug Carrier Systems, 2002
- On the Origin of Cancer CellsScience, 1956